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Fig 2. High intrinsic renal resistance.
Fig 1. Low intrinsic renal resistance.
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1110 Abstracts October 2014underlying cause of both renovascular hypertension and the development of
renal artery stenosis may be increased resistance in distal renal arteries and
arterioles.
Methods: We examined the velocity spectrum of 20 widely patent
renal arteries. The contralateral renal artery was normal in 10 of these and
stenotic or stented in 10. We compared the spectral broadening in these ar-
teries by analyzing their mean to peak systolic ﬂow velocities to see if pa-
tients prone to develop renal artery stenosis had more of their blood ﬂow
at lower velocities, which would be expected if these arteries had lower shear
stress and eddy currents. We examined whether distal renal artery and arte-
riole resistance, which would result in decreased glomerular pressure and
renovascular hypertension, would also account for blood ﬂow effects
inducing the development of proximal renal artery stenosis in a ﬂuid dy-
namic model.
Results: Normal renal arteries when the contralateral artery was also
normal had a mean to peak systolic velocity ratio of 0.61 vs 0.40 in normal
renal arteries when the contralateral renal artery had stenosis or had been
previously stented (P < .001 by t-test). Similar spectral broadening, areas
of low shear stress, and eddy currents were induced in the ﬂuid dynamic
model as the coefﬁcient of resistance was varied to simulate increasing distal
arterial resistance. Fig 1 shows a narrow spectrum with streamlined ﬂow
with low distal renal arterial resistance. Fig 2 shows spectral broadening
with altered shear stress and ﬂow as distal renal arterial resistance is increased
(right).
Conclusions: There is strong evidence that increased distal renal arte-
rial and arteriolar resistance may a primary cause not only of renovascular
hypertension but may also lead to the development of proximal renal artery
stenosis. Proximal renal artery stenosis may often be an effect rather than a
cause of renovascular hypertension explaining why its treatment may be
ineffective.Author Disclosures: A. P. Sawchuk: None;H. Yu:None;M. C. Dalsing:
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Objectives: The aim of this study was to evaluate and compare national
trends in the incidence of unruptured and ruptured thoracoabdominal aortic
aneurysms (TAAAs) and their management by thoracic endovascular aneu-
rysm repair (TEVAR) and conventional open aortic repair (OAR).
Methods: A retrospective analysis of the cross-sectional National
Inpatient Sample (1998-2011) was used to evaluate patient characteristics
and outcomes related to TEVAR and OAR for unruptured (International
Classiﬁcation of Diseases, 9th Revision [ICD-9] 441.7) and ruptured
TAAAs (ICD-9 441.6). Data were extrapolated to represent population-
level statistics through the use of data from the United States Census Bu-
reau. Comparisons between groups were made using descriptive statistics.
Financial data are presented as medians in 2014 US dollars corrected using
the Consumer Price Index.
Results: There were 23,081 patients in the National Inpatient Sample
affected by TAAAs over the 14-year span of this study. The average patient
age was 75 years, 52% were women, and 90% were white. There were
21,727 patients (94%) classiﬁed as unruptured and 1354 as ruptured. The
overall in-hospital mortality rate for patients with unruptured TAAAs was
7% in 1998 and dropped to 6% by 2011. Median hospital charges for this
cohort increased by $11,327 over a decade, from $15,687 in 2001 to
$27,014 by 2011 (P < .001). For patients with ruptured TAAAs, the overall
mortality decreased from60% in 1998 to 41%by 2011 (P< .01). Therewas an
increase in the use ofTEVAR to treat aneurysms from1998 to2011 compared
with OAR, from no cases in 1998 to 177 in 2011 (P < .001) regardless of
rupture status. TEVAR was associated with an overall mortality of 8%
compared with 19% for OAR (P < .001). There was an overall decline in
Fig 1. Observed survival.
Fig 2. Survival for propensity-matched cohorts.
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ruptured TAAA (P < .001).
Conclusions: A decline in the number of TAAA cases was observed
over the study period; however, the costs associated with treatment
increased signiﬁcantly. The overall in-hospital mortality is decreasing for
TAAAs. A sharp rise in the use of endovascular techniques for the manage-
ment of TAAA was seen over the study period. The overall mortality of
TEVAR was signiﬁcantly lower compared with OAR.
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Objectives: Clinically signiﬁcant steal syndrome (SS) occurs in a sub-
set of dialysis patients with arteriovenous (AV) access. Factors associated
with SS are poorly understood. Severe symptoms require access revision
or sacriﬁce, potentially jeopardizing access options. Our objective was to re-
view our dialysis access experience to identify factors associated with SS.
Methods: We reviewed all adult patients undergoing their ﬁrst upper
extremity access, AV ﬁstula (AVF) or AV graft (AVG), between January
2008 and July 2011 at a single center. Medical, demographic, and access
characteristics were collected from our electronic medical record and a local
dialysis center’s database. Patients who required correction of SS were
compared with the larger access cohort. Statistical analysis included the
Fisher exact test and c2 for noncontinuous variables and the unpaired t-
test for continuous variables.
Results: Of 303 patients, 15 required correction for SS (eight of 232
AVF and seven of 71 AVG). Eight were ligated; two were initially banded,
then ligated; and ﬁve underwent distal revascularization with interval ligation.
Coronary artery disease was more prevalent in SS patients (66.7% vs 25%; P ¼
.001); the same was found with peripheral arterial disease (40% vs 13.8%; P ¼
.02). Further, more patients with SS were on Plavix for cardiovascular reasons
(40% vs 9%;P¼ .002). SS only developedwithAVF/AVGusing brachial artery
inﬂow. No cases of SS arose from radial/ulnar inﬂow (P¼ .03). All AVGs with
SS had a straight conﬁguration; no looped AVG developed steal (P ¼ .02).
Other patient characteristics such as age, sex, race, hypertension, diabetes mel-
litus, congestive heart failure, cerebrovascular accident, cause of end-stage renal
disease, and other medication history were not different between groups.
Conclusions: Clinically signiﬁcant SS is associated with disease in coro-
nary and peripheral arterial beds. In addition, the use of brachial artery inﬂow
and straight AVG conﬁguration are associated with SS. Patients with these
characteristics need additional vigilance for steal-associated symptoms.
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Objectives: The current standard of surgical repair for type A aortic
dissection (TAAD) does not guarantee freedom from subsequent aortic op-
erations; therefore, consideration of simultaneous treatment beyond the
ascending aorta is warranted. This study was conducted to report the na-
tional rates and the timing of proximal and distal reoperations after operative
repair of TAAD based on available patient-level admissions data.
Methods: Admissions data for patients with TAAD were identiﬁed
and obtained from Thomson Reuters MarketScan Database using Interna-
tional Classiﬁcation of Diseases, 9th Revision, Clinical Modiﬁcation codes.
From 2003 to 2011, patients aged >18 years with thoracic or thoracoabdo-
minal diagnoses who underwent surgical repair or aortic resection, or both,
were identiﬁed. From this population, 2041 patients with $12 months of
follow-up data who were discharged alive after index admissions for
TAAD were described. Primary outcome measures were rates of reoperation
for any aortic location. Patient demographics, comorbidities at admission,
and interval to reoperation were also obtained from the database.
Results: A total of 3463 patients with TAAD who underwent
repair were identiﬁed. The mortality rate was 7.8% for the initial
repair. Of 3018 patients who were available for follow-up, 2041 pa-
tients had >1 year of follow-up. The mean age was 58.0 6 13.2years, and 70% were male. Eighty-seven patients (4.26%) required
95 reoperations (33.1% of reoperations) for the ascending aorta,
and 162 (7.94%) patients required 192 (66.9%) reoperations for the
descending thoracic aorta. The mean intervals were 436.7 6 593.9
days for ascending aortic surgery and 324.0 6 431.2 days for the
descending thoracic aorta after the initial admission for TAAD surgi-
cal procedures.
Conclusions: TAAD is a highly morbid and mortal diagnosis. The
initial surgery is high-risk, but our data demonstrate that future surgery is
common. In fact, the majority of the repeat surgical procedures are for
descending thoracic aortic complications. We believe that more aggressive
aortic stabilization may be warranted.
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